K220813

Substantially Equivalent

ART-PLAN

Applicant: Therapanacea
Product code: QKB
Advisory panel: Radiology
Date received: 2022-03-21
Decision date: 2022-06-17
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Paris, FR

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.